A General Strategy for the Chemical Aspects of the Safety Assessment of Extractables and Leachables in Pharmaceutical Drug Products: The Chemical Assessment Triad

References

1. 1.↵
   Guidance for Industry. Container Closure Systems for Packaging Human Drugs and Biologics. U.S. Department of Health and Human Services, Food and Drug Administration: Rockville, MD, May, 1999.
2. 2.↵
   Guideline on Plastic Immediate Packaging Materials. European Medicines Agency. CPMP/QWWP/4359/03. EMEA/CVMP/205/04. May 19, 2005.
3. 3.↵
   Safety Thresholds and Best Practices for Extractables and Leachables in Orally Inhaled and Nasal Drug Products. QRI Leachables and Extractables Working Group, September 9, 2006, available at http://www.pqri.org/pdfs/LE-Recommendations-to-FDA-09-29-06.pdf.
4. 4.↵
   1. Martin J.,
   2. Fitzgerald R.,
   3. Pothier N.,
   4. Ding W.

   Recommendations for Testing and Evaluation of Extractables from Single-Use Process Equipment. Bio-Process Systems Alliance, 2010.
5. 5.↵
   1. Jenke D.

   Compatibility of Pharmaceutical Solutions and Contact Materials; Safety Considerations Associated with Extractables and Leachables; J. Wiley and Sons: New York, 2009.